
Dong Keon Yon
researcherMale0.0Global Dominance: 0.00%
Dong Keon Yon is a leading researcher at Kyung Hee University in Seoul, known for his work in public health and epidemiology. He recently gained attention for leading a significant study that suggests the herpes zoster vaccine can reduce the risk of cardiovascular events for up to eight years, particularly among certain demographics such as men under 60 and individuals with unhealthy lifestyles.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Professor Dong Keon Yon from the Kyung Hee University College of Medicine, Seoul, South Korea, is the lead author of the study.
Heart health unexpectedly affected by shingles vaccineFox News·
United States· 2025-05-09
Dong Keon Yon is the director of the study investigating the effects of the herpes zoster vaccine on cardiovascular risk.
Vacuna contra el zóster bajaría riesgo cardíaco 8 años - CienciaABC Color – leading Paraguayan newspaper, est. 1967·
Paraguay· 2025-05-07


